Concepts (229)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Glioblastoma | 16 | 2024 | 3523 | 1.470 |
Why?
|
RNA | 11 | 2023 | 2727 | 1.090 |
Why?
|
Extracellular Space | 5 | 2018 | 565 | 0.850 |
Why?
|
Brain Neoplasms | 18 | 2024 | 9182 | 0.660 |
Why?
|
Neoplastic Cells, Circulating | 3 | 2023 | 958 | 0.590 |
Why?
|
Secretory Vesicles | 3 | 2014 | 128 | 0.550 |
Why?
|
Sepharose | 1 | 2015 | 102 | 0.490 |
Why?
|
Exosomes | 7 | 2019 | 429 | 0.480 |
Why?
|
Glioma | 9 | 2024 | 3523 | 0.450 |
Why?
|
Heparin | 2 | 2015 | 1636 | 0.360 |
Why?
|
RNA Precursors | 1 | 2011 | 197 | 0.340 |
Why?
|
Retroelements | 1 | 2011 | 164 | 0.330 |
Why?
|
RNA, Neoplasm | 3 | 2017 | 751 | 0.300 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2011 | 998 | 0.250 |
Why?
|
Neoplasms | 8 | 2023 | 22386 | 0.240 |
Why?
|
Transport Vesicles | 3 | 2014 | 81 | 0.230 |
Why?
|
Aminolevulinic Acid | 2 | 2022 | 150 | 0.230 |
Why?
|
Isocitrate Dehydrogenase | 2 | 2024 | 954 | 0.230 |
Why?
|
RNA, Messenger | 7 | 2018 | 12813 | 0.230 |
Why?
|
Dermis | 1 | 2024 | 204 | 0.210 |
Why?
|
Chromatography, Gel | 1 | 2023 | 641 | 0.210 |
Why?
|
Protein Binding | 1 | 2015 | 9376 | 0.210 |
Why?
|
Microfluidics | 3 | 2018 | 675 | 0.200 |
Why?
|
Cell Line, Tumor | 14 | 2020 | 17149 | 0.190 |
Why?
|
Ultracentrifugation | 2 | 2018 | 182 | 0.180 |
Why?
|
Electrochemical Techniques | 1 | 2021 | 96 | 0.180 |
Why?
|
Levulinic Acids | 1 | 2019 | 15 | 0.170 |
Why?
|
Cell Communication | 3 | 2019 | 1662 | 0.170 |
Why?
|
Protoporphyrins | 1 | 2019 | 170 | 0.160 |
Why?
|
Reagent Kits, Diagnostic | 1 | 2020 | 239 | 0.150 |
Why?
|
Hydrogels | 1 | 2024 | 745 | 0.150 |
Why?
|
Chemical Precipitation | 1 | 2018 | 175 | 0.150 |
Why?
|
MicroRNAs | 5 | 2019 | 3805 | 0.150 |
Why?
|
Molecular Biology | 2 | 2018 | 573 | 0.140 |
Why?
|
Tumor Microenvironment | 4 | 2022 | 3939 | 0.140 |
Why?
|
Filtration | 1 | 2018 | 228 | 0.140 |
Why?
|
Receptors, Antigen, T-Cell | 2 | 2024 | 2568 | 0.140 |
Why?
|
Humans | 49 | 2024 | 768451 | 0.140 |
Why?
|
Microscopy | 1 | 2021 | 909 | 0.130 |
Why?
|
Muscular Dystrophies | 1 | 2018 | 394 | 0.130 |
Why?
|
Extracellular Fluid | 1 | 2017 | 165 | 0.130 |
Why?
|
Collagen | 1 | 2024 | 2646 | 0.130 |
Why?
|
Animals | 22 | 2024 | 169418 | 0.130 |
Why?
|
Telomerase | 1 | 2020 | 751 | 0.120 |
Why?
|
Photosensitizing Agents | 1 | 2019 | 633 | 0.120 |
Why?
|
Fluorescent Dyes | 2 | 2021 | 1924 | 0.120 |
Why?
|
Immune Evasion | 1 | 2018 | 377 | 0.120 |
Why?
|
RNA, Untranslated | 1 | 2017 | 457 | 0.110 |
Why?
|
Immunotherapy, Adoptive | 1 | 2024 | 1505 | 0.110 |
Why?
|
Parkinson Disease | 2 | 2019 | 2891 | 0.110 |
Why?
|
GTP Cyclohydrolase | 1 | 2013 | 47 | 0.110 |
Why?
|
Alternative Splicing | 1 | 2018 | 1094 | 0.110 |
Why?
|
Neoplastic Stem Cells | 2 | 2018 | 1357 | 0.100 |
Why?
|
Radiation Injuries | 1 | 2020 | 1205 | 0.100 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2020 | 1660 | 0.100 |
Why?
|
Mutation | 7 | 2024 | 30243 | 0.100 |
Why?
|
5' Untranslated Regions | 1 | 2013 | 255 | 0.100 |
Why?
|
alpha-Synuclein | 1 | 2018 | 765 | 0.100 |
Why?
|
Microspheres | 1 | 2015 | 789 | 0.100 |
Why?
|
Mammary Neoplasms, Experimental | 1 | 2014 | 507 | 0.100 |
Why?
|
Biology | 1 | 2013 | 291 | 0.090 |
Why?
|
Electrophoresis, Agar Gel | 1 | 2011 | 206 | 0.090 |
Why?
|
Neurilemmoma | 1 | 2016 | 524 | 0.090 |
Why?
|
Gene Expression Regulation, Neoplastic | 6 | 2018 | 8635 | 0.090 |
Why?
|
Umbilical Veins | 1 | 2011 | 425 | 0.090 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 3 | 2013 | 4586 | 0.090 |
Why?
|
Subarachnoid Hemorrhage | 1 | 2017 | 1041 | 0.080 |
Why?
|
Dystonic Disorders | 1 | 2013 | 352 | 0.080 |
Why?
|
Serum | 1 | 2009 | 208 | 0.080 |
Why?
|
Sequence Analysis, RNA | 3 | 2022 | 2039 | 0.070 |
Why?
|
Nervous System | 1 | 2011 | 547 | 0.070 |
Why?
|
DNA, Complementary | 1 | 2011 | 1992 | 0.070 |
Why?
|
Body Fluids | 2 | 2019 | 322 | 0.070 |
Why?
|
Microfluidic Analytical Techniques | 2 | 2012 | 825 | 0.070 |
Why?
|
Recovery of Function | 1 | 2017 | 2994 | 0.070 |
Why?
|
Gene Transfer Techniques | 1 | 2012 | 1209 | 0.070 |
Why?
|
Dependovirus | 1 | 2012 | 720 | 0.070 |
Why?
|
Tumor Cells, Cultured | 4 | 2017 | 6135 | 0.070 |
Why?
|
Membrane Proteins | 1 | 2023 | 7895 | 0.070 |
Why?
|
Gene Dosage | 1 | 2011 | 1221 | 0.070 |
Why?
|
Recombinant Proteins | 1 | 2016 | 6527 | 0.070 |
Why?
|
HEK293 Cells | 1 | 2015 | 4294 | 0.060 |
Why?
|
Sensitivity and Specificity | 4 | 2024 | 14728 | 0.060 |
Why?
|
Myelodysplastic Syndromes | 1 | 2015 | 1400 | 0.060 |
Why?
|
Mitosis | 1 | 2010 | 1191 | 0.060 |
Why?
|
Gene Expression Profiling | 5 | 2015 | 9507 | 0.060 |
Why?
|
Cytokines | 1 | 2020 | 7449 | 0.060 |
Why?
|
Drug Delivery Systems | 1 | 2016 | 2238 | 0.060 |
Why?
|
Microarray Analysis | 3 | 2012 | 752 | 0.060 |
Why?
|
Mitochondria | 1 | 2017 | 3672 | 0.060 |
Why?
|
Centrifugation, Density Gradient | 2 | 2013 | 298 | 0.050 |
Why?
|
Mice | 8 | 2024 | 82045 | 0.050 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2013 | 16029 | 0.050 |
Why?
|
Mice, Nude | 3 | 2015 | 3635 | 0.050 |
Why?
|
Antibodies, Immobilized | 1 | 2021 | 23 | 0.050 |
Why?
|
Biological Transport | 2 | 2018 | 2089 | 0.050 |
Why?
|
Colorectal Neoplasms | 1 | 2021 | 6978 | 0.050 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2010 | 2434 | 0.050 |
Why?
|
Blood Platelets | 1 | 2011 | 2485 | 0.040 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2015 | 5342 | 0.040 |
Why?
|
Validation Studies as Topic | 1 | 2020 | 162 | 0.040 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2015 | 3623 | 0.040 |
Why?
|
Cell Cycle Proteins | 1 | 2010 | 3463 | 0.040 |
Why?
|
Coloring Agents | 1 | 2021 | 564 | 0.040 |
Why?
|
Optical Phenomena | 1 | 2019 | 106 | 0.040 |
Why?
|
Gene Expression | 3 | 2018 | 7605 | 0.040 |
Why?
|
Myotonic Dystrophy | 1 | 2018 | 80 | 0.040 |
Why?
|
Endothelial Cells | 1 | 2011 | 3586 | 0.040 |
Why?
|
Nasal Cavity | 1 | 2020 | 309 | 0.040 |
Why?
|
Anticoagulants | 1 | 2013 | 4840 | 0.040 |
Why?
|
Area Under Curve | 1 | 2021 | 1640 | 0.030 |
Why?
|
Mutant Proteins | 1 | 2018 | 489 | 0.030 |
Why?
|
Mice, Transgenic | 2 | 2019 | 9558 | 0.030 |
Why?
|
Membrane Potential, Mitochondrial | 1 | 2017 | 297 | 0.030 |
Why?
|
Necrosis | 1 | 2020 | 1621 | 0.030 |
Why?
|
Nuclear Proteins | 1 | 2010 | 5808 | 0.030 |
Why?
|
Muscular Dystrophy, Duchenne | 1 | 2018 | 271 | 0.030 |
Why?
|
Case-Control Studies | 3 | 2024 | 22293 | 0.030 |
Why?
|
Central Nervous System Neoplasms | 1 | 2024 | 928 | 0.030 |
Why?
|
Immunomagnetic Separation | 1 | 2015 | 79 | 0.030 |
Why?
|
Saliva | 1 | 2020 | 854 | 0.030 |
Why?
|
Epitopes | 1 | 2021 | 2526 | 0.030 |
Why?
|
Plasma | 1 | 2018 | 588 | 0.030 |
Why?
|
ROC Curve | 1 | 2021 | 3624 | 0.030 |
Why?
|
Radiotherapy | 1 | 2020 | 1510 | 0.030 |
Why?
|
Lab-On-A-Chip Devices | 1 | 2018 | 446 | 0.030 |
Why?
|
Green Fluorescent Proteins | 1 | 2018 | 2072 | 0.030 |
Why?
|
Female | 10 | 2024 | 396943 | 0.030 |
Why?
|
Cell Biology | 1 | 2013 | 92 | 0.030 |
Why?
|
Male | 9 | 2024 | 364781 | 0.030 |
Why?
|
Cells, Cultured | 2 | 2018 | 19041 | 0.030 |
Why?
|
Neural Stem Cells | 1 | 2019 | 892 | 0.020 |
Why?
|
Dacarbazine | 1 | 2015 | 560 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2020 | 4120 | 0.020 |
Why?
|
Adult | 6 | 2024 | 223542 | 0.020 |
Why?
|
Spheroids, Cellular | 1 | 2013 | 332 | 0.020 |
Why?
|
Codon | 1 | 2013 | 599 | 0.020 |
Why?
|
Surgery, Computer-Assisted | 1 | 2019 | 1005 | 0.020 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2013 | 699 | 0.020 |
Why?
|
Disease Models, Animal | 3 | 2019 | 18388 | 0.020 |
Why?
|
Stem Cells | 1 | 2024 | 3538 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 2020 | 6091 | 0.020 |
Why?
|
Subcellular Fractions | 1 | 2012 | 527 | 0.020 |
Why?
|
Amplified Fragment Length Polymorphism Analysis | 1 | 2010 | 10 | 0.020 |
Why?
|
Magnetite Nanoparticles | 1 | 2012 | 318 | 0.020 |
Why?
|
Aged | 5 | 2024 | 171520 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 2014 | 2017 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2021 | 6856 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2019 | 20231 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2021 | 6537 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2022 | 2531 | 0.020 |
Why?
|
G2 Phase | 1 | 2010 | 136 | 0.020 |
Why?
|
Disease Progression | 2 | 2020 | 13655 | 0.020 |
Why?
|
Proteomics | 1 | 2024 | 3901 | 0.020 |
Why?
|
Open Reading Frames | 1 | 2013 | 812 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2024 | 4642 | 0.020 |
Why?
|
Nucleic Acid Conformation | 1 | 2013 | 899 | 0.020 |
Why?
|
Antigens, Neoplasm | 1 | 2018 | 2003 | 0.020 |
Why?
|
Equipment Design | 1 | 2018 | 3530 | 0.020 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2014 | 757 | 0.020 |
Why?
|
Genes, Neoplasm | 1 | 2011 | 370 | 0.020 |
Why?
|
Genes, Reporter | 1 | 2013 | 1525 | 0.020 |
Why?
|
Cell Survival | 1 | 2019 | 5801 | 0.020 |
Why?
|
Interferon-gamma | 1 | 2018 | 3169 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2020 | 5308 | 0.020 |
Why?
|
Mice, SCID | 1 | 2014 | 2633 | 0.020 |
Why?
|
Cell-Free System | 1 | 2009 | 340 | 0.020 |
Why?
|
Capsid | 1 | 2012 | 437 | 0.020 |
Why?
|
Sequence Alignment | 1 | 2013 | 2184 | 0.020 |
Why?
|
Middle Aged | 5 | 2024 | 223418 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2020 | 5803 | 0.020 |
Why?
|
Prognosis | 2 | 2021 | 30028 | 0.020 |
Why?
|
Antibody Affinity | 1 | 2009 | 252 | 0.020 |
Why?
|
Transduction, Genetic | 1 | 2012 | 903 | 0.020 |
Why?
|
Up-Regulation | 1 | 2018 | 4138 | 0.020 |
Why?
|
Recurrence | 1 | 2021 | 8510 | 0.020 |
Why?
|
Microscopy, Electron | 1 | 2012 | 2565 | 0.020 |
Why?
|
Gene Frequency | 1 | 2015 | 3615 | 0.020 |
Why?
|
Culture Media, Conditioned | 1 | 2009 | 522 | 0.020 |
Why?
|
Age Distribution | 1 | 2014 | 2881 | 0.020 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2019 | 1890 | 0.020 |
Why?
|
tau Proteins | 1 | 2018 | 2129 | 0.020 |
Why?
|
Nanoparticles | 1 | 2019 | 1986 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2014 | 21156 | 0.020 |
Why?
|
Lymphocyte Activation | 1 | 2018 | 5495 | 0.020 |
Why?
|
Surface Properties | 1 | 2009 | 1168 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 1 | 2017 | 8201 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 2014 | 6241 | 0.020 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2024 | 9425 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2013 | 3637 | 0.020 |
Why?
|
Cell Line | 1 | 2019 | 15609 | 0.020 |
Why?
|
Recombinant Fusion Proteins | 1 | 2013 | 3735 | 0.010 |
Why?
|
Software | 1 | 2019 | 4463 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2021 | 14766 | 0.010 |
Why?
|
Alleles | 1 | 2015 | 6890 | 0.010 |
Why?
|
Cost of Illness | 1 | 2014 | 1960 | 0.010 |
Why?
|
Transfection | 1 | 2012 | 5767 | 0.010 |
Why?
|
Research Design | 1 | 2020 | 6217 | 0.010 |
Why?
|
Neoplasm Metastasis | 1 | 2014 | 4931 | 0.010 |
Why?
|
Neovascularization, Pathologic | 1 | 2013 | 2643 | 0.010 |
Why?
|
Transplantation, Heterologous | 1 | 2011 | 2393 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2018 | 14480 | 0.010 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2015 | 3665 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2013 | 5904 | 0.010 |
Why?
|
Models, Biological | 1 | 2019 | 9505 | 0.010 |
Why?
|
Base Sequence | 1 | 2013 | 12428 | 0.010 |
Why?
|
Cell Cycle | 1 | 2010 | 2942 | 0.010 |
Why?
|
Genetic Vectors | 1 | 2012 | 3417 | 0.010 |
Why?
|
Cell Movement | 1 | 2013 | 5223 | 0.010 |
Why?
|
Computational Biology | 1 | 2013 | 3546 | 0.010 |
Why?
|
DNA Repair | 1 | 2010 | 2051 | 0.010 |
Why?
|
Rats | 1 | 2017 | 23839 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2013 | 17647 | 0.010 |
Why?
|
Point-of-Care Systems | 1 | 2009 | 1228 | 0.010 |
Why?
|
DNA Damage | 1 | 2010 | 2461 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2018 | 10273 | 0.010 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2010 | 2964 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2017 | 22365 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 2 | 2019 | 36840 | 0.010 |
Why?
|
Pyrimidines | 1 | 2010 | 3050 | 0.010 |
Why?
|
Cohort Studies | 1 | 2020 | 41797 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2021 | 59680 | 0.010 |
Why?
|
Young Adult | 1 | 2021 | 60045 | 0.010 |
Why?
|
Brain | 1 | 2020 | 27438 | 0.010 |
Why?
|
Adolescent | 1 | 2021 | 89168 | 0.010 |
Why?
|
Signal Transduction | 1 | 2013 | 23638 | 0.010 |
Why?
|
Prostatic Neoplasms | 1 | 2011 | 11206 | 0.000 |
Why?
|
Treatment Outcome | 1 | 2015 | 65409 | 0.000 |
Why?
|
Time Factors | 1 | 2009 | 40271 | 0.000 |
Why?
|
Concepts
(229)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(84)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_